Cargando…
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis
OBJECTIVE: The objective was to determine if dose reduction is non-inferior to full-dose TNFi to maintain low disease activity (LDA) in patients already in remission with TNFi, in axial spondyloarthritis. METHODS: Randomized, parallel, non-inferiority, open-label multicentre clinical trial. Patients...
Autores principales: | Gratacós, Jordi, Pontes, Caridad, Juanola, Xavier, Sanz, Jesús, Torres, Ferran, Avendaño, Cristina, Vallano, Antoni, Calvo, Gonzalo, de Miguel, Eugenio, Sanmartí, Raimon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323809/ https://www.ncbi.nlm.nih.gov/pubmed/30621746 http://dx.doi.org/10.1186/s13075-018-1772-z |
Ejemplares similares
-
Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF): study protocol for a randomized controlled trial
por: Pontes, Caridad, et al.
Publicado: (2015) -
Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study
por: Moreno, Mireia, et al.
Publicado: (2019) -
Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO
por: Llop, Maria, et al.
Publicado: (2022) -
Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition
por: Juanola, Xavier, et al.
Publicado: (2022) -
Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational study
por: Van Rossen, Liz, et al.
Publicado: (2020)